JSMC

Jess S. Morgan & Co Portfolio holdings

AUM $115M
This Quarter Return
+15.05%
1 Year Return
-16.65%
3 Year Return
+69.29%
5 Year Return
10 Year Return
AUM
$102M
AUM Growth
Cap. Flow
+$102M
Cap. Flow %
100%
Top 10 Hldgs %
37.52%
Holding
43
New
43
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 17.42%
2 Technology 14.07%
3 Financials 11.16%
4 Consumer Discretionary 5.42%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SBUX icon
26
Starbucks
SBUX
$101B
$2.61M 2.56%
+29,686
New +$2.61M
JNJ icon
27
Johnson & Johnson
JNJ
$429B
$2.58M 2.53%
+17,710
New +$2.58M
ADBE icon
28
Adobe
ADBE
$146B
$2.54M 2.49%
+7,711
New +$2.54M
DIS icon
29
Walt Disney
DIS
$212B
$2.42M 2.37%
+16,728
New +$2.42M
CRM icon
30
Salesforce
CRM
$241B
$2.3M 2.26%
+14,153
New +$2.3M
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.95M 1.91%
+42,876
New +$1.95M
BMY icon
32
Bristol-Myers Squibb
BMY
$96.5B
$1.75M 1.71%
+27,236
New +$1.75M
XLK icon
33
Technology Select Sector SPDR Fund
XLK
$82.7B
$1.6M 1.57%
+17,428
New +$1.6M
XLV icon
34
Health Care Select Sector SPDR Fund
XLV
$33.9B
$814K 0.8%
+7,996
New +$814K
IGV icon
35
iShares Expanded Tech-Software Sector ETF
IGV
$9.74B
$754K 0.74%
+3,236
New +$754K
XLP icon
36
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
$631K 0.62%
+10,018
New +$631K
AXSM icon
37
Axsome Therapeutics
AXSM
$6.15B
$568K 0.56%
+5,500
New +$568K
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$223K 0.22%
+6,500
New +$223K
ORMP icon
39
Oramed Pharmaceuticals
ORMP
$88.6M
$159K 0.16%
+30,900
New +$159K
RNTX
40
Rein Therapeutics, Inc. Common Stock
RNTX
$31.6M
$72K 0.07%
+125,000
New +$72K
BMY.RT
41
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$68K 0.07%
+22,446
New +$68K
AGEN
42
Agenus
AGEN
$134M
$41K 0.04%
+10,000
New +$41K
USWS
43
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$19K 0.02%
+10,000
New +$19K